Image 1 of 1
Research and Properties
-
This stack contains GLP-RT 20mg and tesamorelin 10mg as separate research compounds.
-
GLP-RT is investigated in connection with GIP, GLP-1, and glucagon receptor signaling, while tesamorelin is studied in relation to GHRH receptor activity and the GH and IGF-1 signaling axis.
-
No. These products are intended exclusively for laboratory research use only (RUO). They are not for human or veterinary use, consumption, diagnostic purposes, or therapeutic applications.
-
Each batch is independently tested using HPLC to assess purity and LC-MS to confirm identity. The corresponding Certificate of Analysis includes the batch number, testing date, and independent laboratory information, and is made available through our COA Library. Contact us to request COAs.
GLP-RT 20mg + KLOW (GHK-Cu 50mg + BPC-157 10mg + TB-500 10mg + KPV 10mg)
A multi-compound research stack containing GLP-RT alongside GHK-Cu, BPC-157, TB-500, and KPV. The individual compounds are investigated across metabolic receptor signaling, extracellular matrix research, cellular migration, vascular pathways, cytoskeletal activity, and inflammatory signaling.